N. Ahuja
Research Subjects
Research Interests
N. Ahuja has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
Aj Lloyd
Wallsend Community Mental Health Team, Sir GB Hunter Hospital, Wallsend, Tyne and Wear, UK; Institute of Neuroscience (Psychiatry), Newcastle University, Royal Victoria Infirmary, Newcastle, UK
1 shared publicationN. Palanichamy
Wallsend Community Mental Health Team, Sir GB Hunter Hospital, Wallsend, Tyne and Wear, UK
1 shared publicationP. Mackin
Institute of Neuroscience (Psychiatry), Newcastle University, Royal Victoria Infirmary, Newcastle, UK; Whitley Bay Community Mental Health Team, Whitley Bay, Tyne and Wear, UK
1 shared publication
Latest Publications
- 18 September 2008
- Published by SAGE Publications in Journal of Psychopharmacology
- Vol. 24 (1) , 125-130
Olanzapine-induced hyperglycaemic coma and neuroleptic malignant syndrome: case report and review of literature
Although the relationship between antipsychotic medication, particularly second-generation antipsychotics (SGAs), and metabolic disturbance is increasingly accepted, there is an important, but little recognised, potential interaction between this and the other important serious adverse effect of neuroleptic malignant syndrome (NMS). We report a case of a 35-year old female who developed new onset type II diabetes mellitus with hyperosmolar hyperglycaemic coma and acute renal failure following treatment with a SGA for a first manic episode. The history is strongly suggestive of concurrent NMS. This case raises important questions about non-ketotic, hyperosmolar diabetic coma with antipsychotics, the possible association between hyperglycaemia and hyperthermia, and the direction of causality in this, the recognition of either syndrome when they co-exist and management issues in such patients. These questions are considered in the context of currently available literature.
- 18 September 2008
- Published by SAGE Publications in Journal of Psychopharmacology
- Vol. 24 (1) , 125-130
Olanzapine-induced hyperglycaemic coma and neuroleptic malignant syndrome: case report and review of literature
Although the relationship between antipsychotic medication, particularly second-generation antipsychotics (SGAs), and metabolic disturbance is increasingly accepted, there is an important, but little recognised, potential interaction between this and the other important serious adverse effect of neuroleptic malignant syndrome (NMS). We report a case of a 35-year old female who developed new onset type II diabetes mellitus with hyperosmolar hyperglycaemic coma and acute renal failure following treatment with a SGA for a first manic episode. The history is strongly suggestive of concurrent NMS. This case raises important questions about non-ketotic, hyperosmolar diabetic coma with antipsychotics, the possible association between hyperglycaemia and hyperthermia, and the direction of causality in this, the recognition of either syndrome when they co-exist and management issues in such patients. These questions are considered in the context of currently available literature.